Utilizing these characteristics, IL-21 performed much better than IL-2 or IL-15 during in vitro generation of antigen-specific CD8+ CTL and in an in vivo murine model of cancer immunotherapy (139, 140). The gene discussed is IL21; the disease is cancer.